ProPhase Labs, Inc.
PRPH
$0.3513
$0.041113.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -178.96% | 27.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -178.96% | 27.16% | |||
| Cost of Revenue | -202.93% | 12.24% | |||
| Gross Profit | 660.00% | 65.34% | |||
| SG&A Expenses | 101.70% | 6.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.02% | 7.59% | |||
| Operating Income | -83.53% | -1.41% | |||
| Income Before Tax | -75.53% | -7.76% | |||
| Income Tax Expenses | 680.38% | -9.66% | |||
| Earnings from Continuing Operations | -363.34% | -7.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -421.62% | -7.05% | |||
| EBIT | -83.53% | -1.41% | |||
| EBITDA | -153.70% | 10.68% | |||
| EPS Basic | -360.60% | -5.95% | |||
| Normalized Basic EPS | -34.34% | -6.66% | |||
| EPS Diluted | -353.66% | -6.06% | |||
| Normalized Diluted EPS | -34.34% | -6.66% | |||
| Average Basic Shares Outstanding | 7.25% | 1.01% | |||
| Average Diluted Shares Outstanding | 7.25% | 1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||